SMAD2 and diabetes mellitus: The protective response we observed during miR-133a overexpression during diabetes involves down-regulation of TGF-β1 and decreased phosphorylation of SMAD2 and reduced ERK1/2 activation (Fig. 5 Summary Diagram).